Continuation Protocol to Protocol BBCO-001

Clinical trial NCT02328482 · COMPLETED

Trial details

NCT number

NCT02328482

Sponsor

Bioblast Pharma Ltd.

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2015-01-01

Primary completion

2017-10-01

Enrollment

9

View on ClinicalTrials.gov